PDCD1 and cancer: Several other studies have also shown prolonged survival outcomes and positive prognostic feature in cases with high baseline PD-1+CD8+ cells (48, 51), which is in contrast with the presence of intratumoral PD-1+CD8+ counterparts that often display exhausted phenotype linked to unfavorable outcomes across a range of human cancers (52, 53).